Results 21 to 30 of about 82,899 (261)

Vasoactive intestinal polypeptide level in gastroesophageal reflux disease before and after surgical treatment

open access: yesZaporožskij Medicinskij Žurnal, 2023
From year to year, wide spread of gastroesophageal reflux disease (GERD) is attracting greater attention of specialists in the field of this pathology diagnosis and treatment.
Ye. I. Haidarzhi   +2 more
doaj   +1 more source

Vasoactive Intestinal Peptide in Checkpoint Inhibitor-Induced Pneumonitis.

open access: yesNew England Journal of Medicine, 2020
Inhaled Vasoactive Intestinal Peptide for Checkpoint Inhibitor Pneumonitis A patient with severe autoimmune pneumonitis from immune checkpoint inhibitor therapy for metastatic melanoma had improved...
B. Frye   +4 more
semanticscholar   +1 more source

Role of vasoactive intestinal peptide in Aspergillus fumigatus-infected cornea [PDF]

open access: yesInternational Journal of Ophthalmology, 2018
AIM: To investigate the anti-inflammatory role of vasoactive intestinal peptide (VIP) in Aspergillus fumigatus (A. fumigatus) ketatitis. METHODS: Expression of VIP was tested by polymerase chain reaction (PCR) in C57BL/6 and BALB/c normal and A ...
Cui Li   +9 more
doaj   +1 more source

Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats [PDF]

open access: yes, 2003
The aim of this work was to study in rats the nasal route for the brain delivery of the vasoactive intestinal peptide (VIP) neuropeptide. After evaluating VIP stability in solutions obtained from nasal washes, the effect of formulation parameters (pH 4-9,
Couet, William   +5 more
core   +3 more sources

Effect of Intraduodenal Bile and Taurodeoxycholate on Exocrine Pancreatic Secretion and on Plasma Levels of Vasoactive Intestinal Polypeptide and Somatostatin in Man [PDF]

open access: yes, 1994
Intraduodenal (i.d.) application of bile or Na-taurodeoxycholate (TDC) dose dependently enhances basal exocrine pancreatic secretion. The hydrokinetic effect is mediated at least in part by secretin.
Fiedler, Fritz   +3 more
core   +1 more source

PACAP and its receptors in cranial arteries and mast cells

open access: yesThe Journal of Headache and Pain, 2018
Background In migraineurs pituitary adenylate cyclase activating peptide1–38 (PACAP1–38) is a potent migraine provoking substance and the accompanying long lasting flushing suggests degranulation of mast cells.
Inger Jansen-Olesen   +1 more
doaj   +1 more source

Vasoactive intestinal peptide-expressing interneurons are impaired in a mouse model of Dravet syndrome

open access: yeseLife, 2019
Dravet Syndrome (DS) is a severe neurodevelopmental disorder caused by pathogenic loss of function variants in the gene SCN1A which encodes the voltage gated sodium (Na+) channel subunit Nav1.1.
Kevin M Goff, Ethan M. Goldberg
semanticscholar   +1 more source

Development by Genetic Immunization of Monovalent Antibodies Against Human Vasoactive Intestinal Peptide Receptor 1 (VPAC1), New Innovative, and Versatile Tools to Study VPAC1 Receptor Function

open access: yesFrontiers in Endocrinology, 2018
Multi-membrane spanning proteins, such as G protein-coupled receptors (GPCRs) and ion channels, are extremely difficult to purify as native proteins. Consequently, the generation of antibodies that recognize the native conformation can be challenging. By
Xavier Peyrassol   +15 more
doaj   +1 more source

A distinctive ligand recognition mechanism by the human vasoactive intestinal polypeptide receptor 2

open access: yesNature Communications, 2022
Vasoactive intestinal polypeptide receptor 2 (VIP2R) is involved in immunity. Here, the authors report two cryo-EM structures of the VIP2R–Gs in complex with the endogenous peptide ligand PACAP27, revealing a unique interaction mode between PACAP27 and ...
Yingna Xu   +15 more
doaj   +1 more source

Chronic alcohol consumption and withdrawal do not induce cell death in the suprachiasmatic nucleus, but lead to irreversible depression of peptide immunoreactivity and mRNA levels [PDF]

open access: yes, 1997
There is evidence that chronic ethanol treatment (CET) disrupts the biological rhythms of various brain functions and behaviors. Because the suprachiasmatic nucleus (SCN) is widely recognized as the dominant pacemaker of the circadian system, we have ...
Almeida, OFX   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy